Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP versus TOBI in cystic fibrosis with Pseudomonas aeruginosa infection
2005-003772-37Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection (2 arms), sponsored by Novartis. Started Nov 2005; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2005-003772-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003772-37.